Access to Care and the Incidence of Endstage Renal Disease Due to Systemic Lupus Erythematosus

被引:29
|
作者
Ward, Michael M. [1 ]
机构
[1] NIAMSD, Intramural Res Program, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ACCESS TO CARE; SOCIOECONOMIC STATUS; ENDSTAGE RENAL DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; SOCIOECONOMIC-STATUS; RISK-FACTORS; NEPHRITIS; ASSOCIATION; RACE; MORBIDITY; INSURANCE; COHORT; HEALTH; ONSET;
D O I
10.3899/jrheum.091199
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Persons with low socioeconomic status have an increased risk of endstage renal disease (ESRD) due to systemic lupus erythematosus (SLE), possibly because of limited access to care. We examined if the incidence of ESRD due to SLE was higher in geographic areas with poorer access to care. Methods. In this population-based ecological study, we tested associations between the incidence of ESRD due to SLE and the proportion of hospitalizations with no insurance, Medicaid or managed care insurance, residence in a primary care-provider shortage area or rural area, and rate of hospitalizations for ambulatory care-sensitive conditions, by ZIP code in California in 1999-2004. Results. The incidence of ESRD due to SLE was higher in ZIP codes with higher proportions of hospitalizations with no insurance (r = 0.22, p<0.0001) or Medicaid (r = 0.21, p<0.0001), and in ZIP codes with higher rates of hospitalizations for ambulatory care-sensitive conditions (r = 0.23, p<0.0001). In multivariate analyses, incidences were higher in ZIP codes with higher proportions of hospitalizations with Medicaid (p<0.0001) and higher rates of hospitalizations for ambulatory care-sensitive conditions (p = 0.06), independent of the socioeconomic status of the ZIP code residents. Conclusion. The incidence of ESRD due to SLE is higher in areas with higher proportions of residents who have public insurance and higher rates of avoidable hospitalizations, suggesting that limited access to care may contribute to this complication of SLE. (First Release April 15 2010; J Rheumatol 2010;37:1158-63; doi:10.3899/jrheum.091199)
引用
收藏
页码:1158 / 1163
页数:6
相关论文
共 50 条
  • [31] End-stage renal disease in systemic lupus erythematosus
    Stone, JH
    Amend, WJC
    Criswell, LA
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (04): : 425 - 426
  • [32] Standardized Incidence Ratios For Cancer After Renal Transplant In Systemic Lupus Erythematosus and Non-Systemic Lupus Erythematosus Recipients.
    Ramsey-Goldman, Rosalind
    Brar, Amarpali
    Salifu, Moro
    Clarke, Ann E.
    Jindal, Rahul M.
    Bernatsky, Sasha
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1244 - S1245
  • [33] Abetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease
    Cardiel, MH
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (01) : 77 - 88
  • [34] Lupus erythematosus as a systemic disease
    Goeckerman, WH
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1923, 80 : 0542 - 0547
  • [35] Renal involvement in systemic lupus erythematosus
    Bruijn, JA
    UPDATE IN PATHOLOGY, PROCEEDINGS, 2003, : 252 - 259
  • [36] SYSTEMIC LUPUS ERYTHEMATOSUS AND RENAL TRANSPLANTATION
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 194 (01): : 86 - &
  • [37] Renal involvement in systemic lupus erythematosus
    Karras, Alexandre
    PRESSE MEDICALE, 2012, 41 (03): : 260 - 266
  • [38] Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry
    Plantinga, Laura
    Lim, S. Sam
    Patzer, Rachel
    McClellan, William
    Kramer, Michael
    Klein, Mitchel
    Pastan, Stephen
    Gordon, Caroline
    Helmick, Charles
    Drenkard, Cristina
    ARTHRITIS CARE & RESEARCH, 2016, 68 (03) : 357 - 365
  • [39] Colitis and Pancreatitis in a Patient with Systemic Lupus Erythematosus: Due to Disease or to Drug?
    Swathi Paleti
    Bharath Yarlagadda
    Anas Gremida
    Muhammad Aziz
    Joshua Hanson
    Denis McCarthy
    Digestive Diseases and Sciences, 2018, 63 : 2206 - 2209
  • [40] Colitis and Pancreatitis in a Patient with Systemic Lupus Erythematosus: Due to Disease or to Drug?
    Paleti, Swathi
    Yarlagadda, Bharath
    Gremida, Anas
    Aziz, Muhammad
    Hanson, Joshua
    McCarthy, Denis
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (09) : 2206 - 2209